Economic Perspectives on Personalized Health Care and Prevention
The objective of this paper is to provide an overview of economic evaluation of personalized medicine, focusing particularly on the use of cost-effectiveness analysis and other methods of valuation. We draw on insights from the literature and our work at the University of California, San Francisco Center for Translational and Policy Research on Personalized Medicine (TRANSPERS). We begin with a discussion of why personalized medicine is of interest and challenges to adoption, whether personalized medicine is different enough to require different evaluation approaches, and what is known about the economics of personalized medicine. We then discuss insights from TRANSPERS research and six areas for future research:
Year of publication: |
2013
|
---|---|
Authors: | Phillips Kathryn A. ; Ann, Sakowski Julie ; Su-Ying, Liang ; Ponce Ninez A. |
Published in: |
Forum for Health Economics & Policy. - De Gruyter, ISSN 1558-9544. - Vol. 16.2013, 2, p. 57-86
|
Publisher: |
De Gruyter |
Saved in:
Online Resource
Saved in favorites
Similar items by subject
-
Find similar items by using search terms and synonyms from our Thesaurus for Economics (STW).